TLR/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia

The objective of the present work was to find a novel anti-inflammatory agent that may block the mTOR/TLR inflammatory signaling pathways and might pave the way for the treatment of neuroinflammatory SCZ. Data were collected from experimental and clinical studies published in English between 1998 and October 2022 from Google Scholar, PubMed, Scopus, and the Cochrane library.PMID:37955633 | DOI:10.1139/cjpp-2023-0107

Source: Canadian Journal of Physiology and Pharmacology - November 13, 2023 Category: Drugs & Pharmacology Authors: Naser-Aldin Lashgari Nazanin Momeni Roudsari Hedieh Sadat Shamsnia Maryam Shayan Saeideh Momtaz Amir Hossein Abdolghaffari Source Type: research